Inventor · disambiguated record
Melinda K. Nelson
Also filed as: NELSON MELINDA · NELSON MELINDA K
12 granted patents·2 pending applications·1,011 citations·filing 1987–2005
95Inventor score
Top patents by PatentIndex Score
14 records- 0196US5268209ANicotine packaging materialsALZA CORP·Filed 1991·Granted Dec 7, 1993·79 cites·16 claims
- 0296US5004610ASubsaturated nicotine transdermal therapeutic systemALZA CORP·Filed 1990·Granted Apr 2, 1991·166 cites·29 claims
- 0396US4788062ATransdermal administration of progesterone, estradiol esters, and mixtures thereofALZA CORP·Filed 1987·Granted Nov 29, 1988·231 cites·42 claims
- 0495US5077104ANicotine packaging materialsALZA CORP·Filed 1989·Granted Dec 31, 1991·86 cites·7 claims
- 0592US7011844B2Formulations for the administration of fluoxetineALZA CORP·Filed 2002·Granted Mar 14, 2006·29 cites·10 claims
- 0690US6512010B1Formulations for the administration of fluoxetineALZA CORP·Filed 1997·Granted Jan 28, 2003·76 cites·34 claims
- 0787US5364630ASubsaturated nicotine transdermal therapeutic systemALZA CORP·Filed 1993·Granted Nov 15, 1994·87 cites·18 claims
- 0884US6165497ASubsaturated nicotine transdermal therapeutic systemALZA CORP·Filed 1991·Granted Dec 26, 2000·58 cites·13 claims
- 0984US5633008AMethod of administering nicotine transdermallyFiled 1993·Granted May 27, 1997·66 cites·9 claims
- 1082US5508038APolyisobutylene adhesives for transdermal devicesALZA CORP·Filed 1990·Granted Apr 16, 1996·73 cites·20 claims
- 1179US6001390AFormulations for transdermal delivery of pergolideALZA CORP·Filed 1996·Granted Dec 14, 1999·41 cites·30 claims
- 1263US6572879B1Formulations for transdermal delivery of pergolideALZA CORP·Filed 1995·Granted Jun 3, 2003·19 cites·47 claims
- 1362US2005186277A1Novel formulations for the administration of fluoxetineFiled 2005·Application pending·0 cites
- 1458US2004209909A1Novel formulations for transdermal delivery of pergolideYUM SU IL·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Melinda K. Nelson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →